Qingqing Leng

ORCID: 0009-0009-6256-135X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • RNA Interference and Gene Delivery
  • Advanced biosensing and bioanalysis techniques
  • Virus-based gene therapy research
  • Enzyme Structure and Function
  • Biopolymer Synthesis and Applications
  • DNA and Nucleic Acid Chemistry
  • Extracellular vesicles in disease
  • MicroRNA in disease regulation
  • DNA Repair Mechanisms
  • Amino Acid Enzymes and Metabolism
  • Signaling Pathways in Disease
  • Cancer Research and Treatments
  • Nanoplatforms for cancer theranostics
  • Transgenic Plants and Applications
  • Biochemical and Molecular Research
  • CRISPR and Genetic Engineering
  • Cell Adhesion Molecules Research
  • Immune cells in cancer
  • Immunotherapy and Immune Responses
  • Antimicrobial Peptides and Activities
  • Biochemical and Structural Characterization

Hebei University
2023-2025

ShanghaiTech University
2023-2024

University of Maryland, Baltimore
2005-2024

University of Maryland, College Park
2012

Acquired drug resistance to mycotic infections is rapidly emerging as a major medical problem.Opportunistic fungal create therapeutic challenges, particularly in high risk immunocompromised patients with AIDS, cancer, and those undergoing transplantation.Higher mortality and/or morbidity rates due invasive mycosis have been increasing over the last 20 years, light of growing commonly used antibiotics, novel antifungal drugs approaches are required.Currently there considerable interest...

10.1358/dof.2010.035.03.1452077 article EN Drugs of the Future 2010-01-01

Abstract In plants, the rapid accumulation of proline is a common response to combat abiotic stress 1–7 . Delta-1-pyrroline-5-carboxylate synthase (P5CS) rate-limiting enzyme in synthesis, catalysing initial two-step conversion from glutamate 8 Here we determine first structure plant P5CS. Our results show that Arabidopsis thaliana P5CS1 (AtP5CS1) and P5CS2 (AtP5CS2) can form enzymatic filaments substrate-sensitive manner. The destruction AtP5CS by mutagenesis leads significant reduction...

10.1038/s41477-024-01697-w article EN cc-by Nature Plants 2024-05-13

Successful gene therapy depends on the development of efficient, non-toxic delivery systems. To accomplish this objective, our laboratory has focused solid-phase synthesized peptide carriers, in which amino acid sequence can be varied precisely to augment intracellular DNA transport. We previously determined that linear and branched co-polymers histidine lysine combination with liposomes enhanced efficiency transfection. In study, we have modified two histidine-lysine (HK) peptides by adding...

10.1093/nar/gni040 article EN cc-by-nc Nucleic Acids Research 2005-02-23

Sequence-specific gene silencing with small interfering RNA (siRNA) has transformed basic science research, and the efficacy of siRNA therapeutics toward a variety diseases is now being evaluated in pre-clinical clinical trials.Despite its potential value, highly negatively charged classic delivery problem requiring transport across cell membranes to cytosol.Consequently, carrier development for one most important problems solve before can achieve widespread use.An assortment non-viral...

10.1358/dof.2009.034.09.1413267 article EN Drugs of the Future 2009-01-01

The elevated levels of lactate in tumor tissue play a pivotal role fostering an immunosuppressive microenvironment. Therefore, efficiently reducing to reprogram immune microenvironment (TIM) is considered crucial step for boosted immunotherapy. Here, high-lactate-metabolizing photosynthetic bacteria (LAB-1) selectively screened TIM reprogramming, which then improves the efficacy culture medium LAB-1 screening initially developed through orthogonal experiment, simulating (TME) and utilizing...

10.1002/adma.202405930 article EN Advanced Materials 2024-06-25

Genome editing with the use of zinc finger nucleases has been successfully applied to variety a eukaryotic cells. Furthermore, proof concept for this approach extended diverse animal models from

10.1358/dof.2012.037.03.1779022 article EN Drugs of the Future 2012-01-01

10.1016/j.bbrc.2023.08.023 article EN publisher-specific-oa Biochemical and Biophysical Research Communications 2023-08-22

10.1016/j.bbrc.2024.150566 article EN Biochemical and Biophysical Research Communications 2024-08-17

Glutamate kinase (GK) is the first committed enzyme in proline biosynthesis pathway. Belonging to amino acid (AAK) superfamily, most prokaryotic GKs have an additional PseudoUridine synthase and Archaeosine transglycosylase (PUA) domain at C-terminus, while function of PUA GK poorly understood. Here, we find that Escherichia coli (EcGK) assembles into filaments bundles state apo binding. Using cryogenic electron microscopy, determine high-resolution structures EcGK bundles. The necessary for...

10.1101/2024.09.19.614007 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2024-09-20

Abstract In plants, the rapid accumulation of proline is a common response to combat abiotic stress. Delta-1-pyrroline-5-carboxylate synthase (P5CS) rate-limiting enzyme in synthesis, catalyzing initial two-step conversion from glutamate proline. Here, we determine first structure plant P5CS. Our results show that Arabidopsis thaliana P5CS2 (atP5CS2) can form enzymatic filaments substrate-sensitive manner. The destruction atP5CS by mutagenesis leads significant reduction activity....

10.1101/2023.09.07.556688 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2023-09-08
Coming Soon ...